An overview of the neuroleptic malignant syndrome (NMS) is presented. Its clinical manifestations, pathogenesis, and current treatment are discussed. An increased appreciation of the syndrome may result in more timely interventions and reduce morbidity and mortality in this disorder.
BourgeoisM., TignolJ., HenryP.Syndromes malins et morts subites au cours des traitements par neuroleptiques simples et retard.Ann Med Psychol (Paris)1971; 2: 729–746.
3.
FabreS., GervaisC., ManuelC., Vic-DupontV.Le syndrome malin des neuroleptiques: a propos de 7 cas.Encephale1977; 3: 321–326.
4.
AllanR.N., WhiteH.C.Side effects of parenteral long-acting phenothiazines.Br Med J1972; 1: 221.
5.
CopeR.V., GreggE.M.Neuroleptic malignant syndrome.Br Med J1983; 286: 1938.
ItohH., OhtsukaN., OgitaK., YagiG., MiuraS., KogaY.Malignant neuroleptic syndrome — its present status in Japan and clinical problems.Folia Psychiatr Neurol Jpn1977; 31: 565–576.
8.
SinghG.The malignant neuroleptic syndrome (a review with report of three cases).Indian J Psychiatry1981; 23: 179–183.
ShermanC.B., HashimotoF., DavidsonE.J.Gas-producing Escherichia coli fasciitis in a patient with the neuroleptic malignant syndrome (ltr to ed).JAMA1983; 250: 361.
24.
GrunhausL., SancoviciS., RimonR.Neuroleptic malignant syndrome due to depot fluphenazine.J Clin Psychiatry1979; 40: 99–100.
25.
GellerB., GreydanusD.E.Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: two case reports with a literature review.J Clin Psychiatry1979; 40: 102–103.
26.
DelayJ., DenikerP.Drug-induced extrapyramidal syndromes. In: VinkenP.J., BruynG.W., eds. Handbook of clinical neurology, vol 6, Diseases of the Basal Ganglia.Amsterdam: North Holland Publishing Co, 1968: 248–266.
27.
ChayasirisobhonS., CullisP., VeeramasuneniR.R.Occurrence of neuroleptic malignant syndrome in a narcoleptic patient.Hosp Community Psychiatry1983; 34: 548–550.
28.
BurkeR.E., FahnS., MayeuxR., WeinbergH., LouisK., WillnerJ.H.Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.Neurology (NY)1981; 31: 1022–1026.
29.
ToruM., MatsudaO., MakiguchiK., SuganoK.Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs.J Nerv Ment Dis1981; 169: 324–327.
30.
MoyesD.Malignant hyperpyrexia caused by trimeprazine.Br J Anaesth1973; 45: 1163–1164.
31.
SpringG., FrankelM.New data on lithium and haloperidol incompatibility.Am J Psychiatry1981; 138: 818–821.
32.
CaroffS., RosenbergH., GerberJ.C.Neuroleptic malignant syndrome and malignant hyperthermia (ltr to ed).J Clin Psychopharmacol1983; 3: 120–121.
33.
BehrmanS.Mutism induced by phenothiazines.Br J Psychiatry1972; 121: 599–604.
34.
Tae-YulL., TollefsonG.Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.Biol Psychiatry1983; 18: 1441–1448.
35.
McEvoyJ.P., LohrJ.B.Diazepam for catatonia.Am J Psychiatry1984; 141: 284–285.
36.
CaroffS.N., RosenbergH., FletcherJ., HilfM., Heiman-PattersonT.D.Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Presented at the 138th annual meeting of the American Psychiatric Association, Dallas, Texas, May 18–24, 1985.
DowneyG.P., RosenbergM., CaroffS.Neuroleptic malignant syndrome: patient with unique clinical and physiologic features.Am J Med1984; 77: 338–340.
50.
CoonsD.J., HillmanF.J., MarshallR.W.Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report.Am J Psychiatry1982; 139: 944–945.
51.
CaroffS., RosenbergH., HilfM.Dantrolene does not inhibit fluphenazine contractures in vitro (abstract).Pharmacologist1983; 25: 130.
52.
GranatoJ.E., SternB.J.; RingelA.Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.Ann Neurol1983; 14: 89–90.
53.
BondW.S.Detection and management of the neuroleptic malignant syndrome.Clin Pharm1984; 3: 302–307.
54.
GreenbergL.B., GujavartyK.The neuroleptic malignant syndrome: review and report of three cases.Compr Psychiatry1985; 26: 63–70.
55.
JesseeS.S., AndersonG.F.ECT in the neuroleptic malignant syndrome: case report.J Clin Psychiatry1983; 44: 186–188.
56.
LazarusA.Treatment of neuroleptic malignant syndrome with electroconvulsive therapy.J Nerv Ment Dis1986; 174: 47–49.
57.
PowersP., DouglassT.S., WaziriR.Hyperpyrexia in catatonic states.Dis Nerv Syst1976; 37: 359–361.
58.
HughesJ.R.ECT during and after the neuroleptic malignant syndrome: case report.J Clin Psychiatry1986; 47: 42–43.
59.
RegesteinQ.R., AlpertJ.S., ReichP.Sudden catatonic stupor with disastrous outcome.JAMA1977; 238: 618–620.
